GlassScriptPhysician profile
Viswanath Natesan
NPI 1336117928
$8,368.14
in general payments reported to CMS, 2019-2025
14 companies · $725 in 2025
The $725 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,034 · 2020: $1,632 · 2021: $132 · 2022: $164 · 2023: $961 · 2024: $2,721 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,855 · Food and Beverage: $1,372 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,855.26 |
| Food and Beverage | $1,372.13 |
| Education | $178.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,070.24 | 2019-2024 | Xact, Optis |
| Medtronic, INC. | $1,275.10 | 2023-2024 | Turbohawk, Hawkone |
| Medtronic Vascular, INC. | $914.96 | 2019 | |
| Boston Scientific Corporation | $806.96 | 2019-2025 | Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor |
| Artivion, INC. | $490.62 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.68 | 2020-2025 | Lifevest |
| Abiomed | $150.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $129.97 | 2023-2025 | Camzyos, Eliquis |
| Lexicon Pharmaceuticals, INC. | $119.85 | 2023 | Inpefa |
| Cordis US Corp. | $68.29 | 2023 | |
| Bard Peripheral Vascular, INC. | $50.00 | 2023 | |
| Angiodynamics, INC. | $23.14 | 2024 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $15.85 | 2024 | |
| Amgen INC. | $13.64 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viswanath Natesan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.